| 摘要 |
<p>There is provided a method of protecting individuals from contracting HIV by administering either a vector or a vaccine containing a sequence encoding the Δ32 mutation. Also provided is a method of decreasing the amount of HIV co-receptors present on the cell surface by administering a compound including a sequence encoding the Δ32 mutation in a pharmaceutically acceptable carrier. Also provided is a compound for decreasing the amount of HIV co-receptors present in the cell surface, the compound having a sequence encoding the Δ32 mutation in a pharmaceutically acceptable carrier. Also provided is a vector containing a sequence encoding the Δ32 mutation. An assay for testing the efficacy of HIV treatment is also provided, the assay includes a detector for detecting the presence of the Δ32 mutation in cells.</p> |
